William Blair downgraded Kinnate Biopharma (KNTE) to Market Perform from Outperform after Kinnate announced an agreement to be acquired by Xoma Corporation (XOMA).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on KNTE: